Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE114435 |
Determining ELL2 direct targets via ChIPseq
|
2 | Christine Milcarek | May 15, 2018 | ||||
GSE108347 |
Genome-wide analysis of cell cycle-specific SF3B1-chromatin interactions and its effect on RNA splicing
|
7 | MANOJ PILLAI | May 15, 2018 | ||||
GSE99171 |
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [ChIP-seq]
|
15 | Phillip H Koeffler | May 15, 2018 | ||||
GSE109012 |
CHD4 and the NuRD complex directly control cardiac sarcomere formation
|
21 | Austin J Hepperla | May 15, 2018 | ||||
GSE114385 |
A somatically acquired enhancer of the androgen receptor is a noncoding driver in advanced prostate cancer
|
33 | Matthew Freedman | May 15, 2018 | ||||
GSE99183 |
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy NA-seq (time course) May 15, 2018 approved TSV
|
49 |
|
Phillip H Koeffler | May 15, 2018 |